Add BrightSurf on Google Email

Treatment for Parkinson’s could now get even better

A new study from the University of Copenhagen has made significant breakthroughs in treating Parkinson's disease by targeting specific neurons in the brainstem. By stimulating excitatory neurons in the caudal area of the pedunculopontine nucleus, researchers were able to restore normal walking function in mice with Parkinson's symptoms.

SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalNature Communications·TypeExperimental study·DateFeb 18, 2022

Heart attack survivors may be less likely to develop Parkinson’s disease

Researchers found that heart attack survivors were less likely to develop Parkinson's disease over a 21-year follow-up period. The study adjusted for various factors and found an inverse relationship between heart attacks and Parkinson's risk, suggesting cardiac rehabilitation should focus on preventing other cardiovascular diseases.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateFeb 16, 2022

Flavonoids may reduce mortality risk for people with Parkinson’s Disease

A recent study found that people with Parkinson's Disease who consume more flavonoids have a lower mortality risk than those who don't. The researchers discovered that higher flavonoid intake is associated with improved survival rates in both men and women, particularly when it comes to anthocyanin-rich foods like berries and red wine.

SourcePenn State·JournalNeurology·TypeObservational study·DateJan 26, 2022

Active ingredient in cannabis protects aging brain cells

Researchers found that CBN preserves mitochondrial function and prevents oxidative damage to nerve cells, suggesting potential for treating age-related neurodegenerative diseases like Alzheimer's. The compound works independently of cannabinoid receptors, making it a promising therapeutic option.

SourceSalk Institute·JournalFree Radical Biology and Medicine·DateJan 24, 2022

Disease-modifying antirheumatic drugs do not seem to protect people with rheumatoid arthritis against Parkinson’s disease

A new study found that disease-modifying antirheumatic drugs do not protect people with rheumatoid arthritis from developing Parkinson's disease. However, using chloroquine or hydroxychloroquine was associated with a lower risk of PD. The study controlled for various factors, including comorbidities and age.

SourceUniversity of Eastern Finland·JournalNeurology·DateJan 24, 2022

Researchers led by UCLA Health call for more work to address overlooked issues affecting women with Parkinson’s Disease

Researchers identified gaps in care and treatment for women with Parkinson's Disease, highlighting the need for personalized medicine and psychosocial support. The study calls for increased attention to sex and gender differences in PD management.

SourceUniversity of California - Los Angeles Health Sciences·JournalMovement Disorders·TypeCommentary/editorial·DateJan 21, 2022

Aerobe exercise has a positive effect on brain function Parkinson's disease patients

Regular aerobic exercise has been shown to strengthen brain networks between spared regions, improve grey-matter volume, and enhance movement control in individuals with Parkinson's disease. The study published in Annals of Neurology suggests that exercise can stimulate compensatory capacity in the brain, leading to reduced symptoms.

SourceRadboud University Medical Center·JournalAnnals of Neurology·TypeRandomized controlled/clinical trial·DateJan 17, 2022

New knowledge about the happiness hormone dopamine

Researchers at the University of Bergen have discovered a new understanding of dopamine's regulatory mechanisms, which could lead to breakthroughs in treating neurodegenerative diseases. The study found that dopamine can bind to an enzyme called tyrosine hydroxylase, inactivating it and controlling its own production.

SourceThe University of Bergen·JournalNature Communications·DateJan 11, 2022

Transforming "undone science" into "done science"

Researchers at Bar-Ilan University used a crowd-sourced approach to test the effectiveness of mannitol in treating Parkinson's disease. The study, published in BioSocieties, chronicles the story of CliniCrowd, an Israeli company that recruited patients and collected data on mannitol's effects.

SourceBar-Ilan University·JournalBioSocieties·DateDec 22, 2021

Parkinson’s protein blueprint could help fast-track new treatments

Researchers have solved a decade-long mystery about the PINK1 protein, which plays a critical role in early onset Parkinson's disease. The discovery provides an unprecedented view of the protein and its activation process, paving the way for developing therapeutic agents that could slow or stop the progression of Parkinson's disease.

SourceWalter and Eliza Hall Institute·JournalNature·TypeExperimental study·DateDec 22, 2021

Veterans with mild traumatic brain injury show premature cognitive decline, in some ways comparable to that of people with early Parkinson's Disease and significantly worse than that of healthy non-veterans

Young veterans with mTBI experience premature cognitive decline in specific domains, matching elder normative scores and early-stage Parkinson's patients. The study highlights the significant negative impact of mTBI on cognitive function compared to healthy non-veterans.

SourcePLOS·JournalPLOS ONE·DateNov 17, 2021

Vascular defects appear to underlie the progression of Parkinson's disease

Researchers identified a significant vascular defect in patients with moderately severe Parkinson's disease, which may explain earlier study findings and provide a new target for therapeutic intervention. The discovery highlights the blood-brain barrier's crucial role in neurodegenerative diseases like Parkinson's.

SourceGeorgetown University Medical Center·JournalNeurology Genetics·TypeRandomized controlled/clinical trial·DateNov 12, 2021

Deterioration of brain cells in Parkinson’s disease is slowed by blocking the Bach1 protein, preclinical study shows

A preclinical study found that blocking the Bach1 protein slowed brain cell deterioration in Parkinson's disease. The researchers identified a potent inhibitor of Bach1 called HPPE, which protected cells from inflammation and oxidative stress, and showed promise as a potential therapeutic target.

SourceMedical University of South Carolina·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 25, 2021

Skin-inspired sensors show how our body moves

Scientists at the University of Groningen developed wearable, stitchable, and sensitive sensors from flexible polymers and carbon fibre. These sensors can measure body position, movement, and touch, offering new possibilities for health monitoring and athlete performance tracking.

SourceUniversity of Groningen·Journalnpj Flexible Electronics·TypeExperimental study·DateOct 21, 2021

Neuroscientists see how practice really does make perfect

Researchers at Duke University used new tools to monitor neurons and analyze machine learning data to see how zebra finches practice their courtship calls. They found that a neurotransmitter called noradrenaline shuts down variability in the song, making it more precise when performed under pressure.

SourceDuke University·JournalNature·TypeData/statistical analysis·DateOct 21, 2021

Frontrunner target for Parkinson’s Disease may only be relevant for small fraction of patients

A recent study suggests that targeting alpha-synuclein protein in Parkinson's disease may not be sufficient to cure most patients. Instead, resolving brain inflammation caused by dysfunctional interferon-beta receptor signaling may hold the key to developing more effective treatments.

Research shows promising results for Parkinson's disease treatment

Researchers at Carnegie Mellon University have found a way to make deep brain stimulation (DBS) more precise, resulting in therapeutic effects that outlast what is currently available. The new protocol uses short bursts of electrical stimulation to target specific neuronal subpopulations, providing longer-lasting benefits.

SourceCarnegie Mellon University·JournalScience·TypeRandomized controlled/clinical trial·DateOct 7, 2021

Researchers improve method to map brain cell connectivity

Scientists have developed an improved technique to trace brain connections between neurons in zebrafish using vesicular stomatitis virus (VSV), enabling the visualization of connected neurons up to five days after infection. This breakthrough could provide insights into brain network connectivity repair after injury or disease.

SourceVirginia Tech·JournalFrontiers in Neuroanatomy·TypeExperimental study·DateOct 6, 2021

New study sheds light on lives of people with Parkinson’s and their carers

A new European survey sheds light on the lives of people with Parkinson's disease and their carers, revealing a wide range of non-motor symptoms affecting quality of life. The study highlights the importance of individualized management and improved clinical practice in addressing the unique challenges faced by patients and caregivers.

SourceIOS Press·JournalJournal of Parkinson’s Disease·TypeCase study·DateAug 31, 2021